Literature DB >> 2851502

Ascorbate autoxidation in the presence of iron and copper chelates.

G R Buettner1.   

Abstract

Chelates can inhibit the iron- and copper-catalyzed autoxidation of ascorbate at pH 7.0. Diethylenetriaminepentaacetic acid (DTPA or DETAPAC) and Desferal (deferoximane mesylate) slow the iron-catalyzed oxidation of ascorbate as effectively as reducing the trace levels of contaminating iron in buffers with Chelex resin. DETAPAC, EDTA and HEDTA (N-(2-hydroxyethyl)-ethylenediaminetriacetic acid) are effective at slowing the copper-catalyzed autoxidation of ascorbate while Desferal is ineffective. The ability to inhibit ascorbate autoxidation appears to parallel the rate of the reaction of superoxide with the iron chelate.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2851502     DOI: 10.3109/10715768609051638

Source DB:  PubMed          Journal:  Free Radic Res Commun        ISSN: 8755-0199


  26 in total

Review 1.  Ascorbic acid: chemistry, biology and the treatment of cancer.

Authors:  Juan Du; Joseph J Cullen; Garry R Buettner
Journal:  Biochim Biophys Acta       Date:  2012-06-20

2.  Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.

Authors:  Qi Chen; Michael Graham Espey; Murali C Krishna; James B Mitchell; Christopher P Corpe; Garry R Buettner; Emily Shacter; Mark Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

Review 3.  Pharmacological Ascorbate as a Means of Sensitizing Cancer Cells to Radio-Chemotherapy While Protecting Normal Tissue.

Authors:  Joshua D Schoenfeld; Matthew S Alexander; Timothy J Waldron; Zita A Sibenaller; Douglas R Spitz; Garry R Buettner; Bryan G Allen; Joseph J Cullen
Journal:  Semin Radiat Oncol       Date:  2019-01       Impact factor: 5.934

Review 4.  The chemistry and antioxidant properties of tocopherols and tocotrienols.

Authors:  A Kamal-Eldin; L A Appelqvist
Journal:  Lipids       Date:  1996-07       Impact factor: 1.880

5.  Methionine motifs of copper transport proteins provide general and flexible thioether-only binding sites for Cu(I) and Ag(I).

Authors:  Jeffrey T Rubino; Pamela Riggs-Gelasco; Katherine J Franz
Journal:  J Biol Inorg Chem       Date:  2010-05-01       Impact factor: 3.358

6.  Monitoring of ascorbate at a constant rate in cell culture: effect on cell growth.

Authors:  T Chepda; M Cadau; P Girin; J Frey; A Chamson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-01       Impact factor: 2.416

7.  O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.

Authors:  Joshua D Schoenfeld; Zita A Sibenaller; Kranti A Mapuskar; Brett A Wagner; Kimberly L Cramer-Morales; Muhammad Furqan; Sonia Sandhu; Thomas L Carlisle; Mark C Smith; Taher Abu Hejleh; Daniel J Berg; Jun Zhang; John Keech; Kalpaj R Parekh; Sudershan Bhatia; Varun Monga; Kellie L Bodeker; Logan Ahmann; Sandy Vollstedt; Heather Brown; Erin P Shanahan Kauffman; Mary E Schall; Ray J Hohl; Gerald H Clamon; Jeremy D Greenlee; Matthew A Howard; Michael K Schultz; Brian J Smith; Dennis P Riley; Frederick E Domann; Joseph J Cullen; Garry R Buettner; John M Buatti; Douglas R Spitz; Bryan G Allen
Journal:  Cancer Cell       Date:  2017-08-14       Impact factor: 31.743

8.  Is brain iron trafficking part of the physiology of the amyloid precursor protein?

Authors:  Danielle K Bailey; Daniel J Kosman
Journal:  J Biol Inorg Chem       Date:  2019-10-01       Impact factor: 3.358

9.  NADPH-dependent lipid peroxidation capacity in unfixed tissue sections: characterization of the pro-oxidizing conditions and optimization of the histochemical detection.

Authors:  M Thomas; W M Frederiks; C J Van Noorden; K S Bosch; A Pompella
Journal:  Histochem J       Date:  1994-03

10.  Ascorbic acid and tetrahydrobiopterin potentiate the EDHF phenomenon by generating hydrogen peroxide.

Authors:  Ambroise Garry; David H Edwards; Ian F Fallis; Robert L Jenkins; Tudor M Griffith
Journal:  Cardiovasc Res       Date:  2009-07-10       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.